1. Adelaide Research & Scholarship

Search


Current filters:

Start a new search
Add filters:

Use filters to refine the search results.

 | 
Results 31-40 of 49 (Search time: 0.004 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2009Risk assessment and communication tools for genotype associations with multifactorial phenotypes: The concept of "edge effect" and cultivating an ethical bridge between omics innovations and societyOzdemir, V.; Suarez-Kurtz, G.; Stenne, R.; Somogyi, A.; Someya, T.; Kayaalp, S.; Kolker, E.
2001The relationship between mood state and plasma methadone concentration in maintenance patientsDyer, K.; White, J.; Foster, D.; Bochner, F.; Menelaou, A.; Somogyi, A.
2006ABCB1 genetic variability and methadone dosage requirements in opioid-dependent individualsColler, J.; Barratt, D.; Dahlen, K.; Loennechen, M.; Somogyi, A.
1996The influence of CYP2D6 polymorphism and quinidine on the disposition and antitussive effect of dextromethorphan in humans.Capon, D.; Bochner, F.; Kerry, N.; Mikus, G.; Danz, C.; Somogyi, A.
2004Clinical inhibition of CYP2D6-catalysed metabolism by the antianginal agent perhexilineDavies, B.; Coller, J.; James, H.; Gillis, D.; Somogyi, A.; Horowitz, J.; Morris, R.; Sallustio, B.
2000Steady-state pharmacokinetics of (R)- and (S)-methadone in methadone maintenance patientsFoster, D.; Somogyi, A.; Dyer, K.; White, J.; Bochner, F.
1997Characterization of the human cytochrome P450 enzymes involved in the metabolism of dihydrocodeine.Kirkwood, L.; Nation, R.; Somogyi, A.
1997Association between CYP2C19 genotype and proguanil oxidative polymorphism.Coller, J.; Somogyi, A.; Bochner, F.
1999Comparison of (S)-mephenytoin and proguanil oxidation in vitro: contribution of several CYP isoforms.Coller, J.; Somogyi, A.; Bochner, F.
2004Impact of concentration and rate of intraluminal drug delivery on absorption and gut wall metabolism of verapamil in humansGlaeser, H.; Drescher, S.; Hofmann, U.; Heinkele, G.; Somogyi, A.; Eichelbaum, M.; Fromm, M.

Discover